Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Phenocell & Amarna Win Eurostars Grant
Phenocell SAS and Amarna Therapeutics have been awarded the prestigious Eurostars grant to advance their collaborative gene therapy platform targeting dry age-related macular degeneration (AMD). This partnership combines Phenocell’s innovative in vitro AMD disease model with Amarna’s proprietary gene delivery…
ACELYRIN Halts Izokibep Development | OBN
ACELYRIN has announced that the Phase 2b/3 clinical trial evaluating izokibep for non-infectious, non-anterior uveitis did not achieve its primary endpoint. The trial results did not demonstrate a statistically significant improvement in time to treatment failure versus placebo. Consequently, the…
Top 12 Ophthalmic Drugs That Received FDA Approval
2024 Recap is here! Click to review:Top 8 FDA Approvals in Opthalmology In a series of groundbreaking developments, the FDA has approved a range of innovative drugs in 2023, heralding a new era in ophthalmic treatments. Here’s an in-depth look…
Tenpoint and Visus Merge to Advance Eye Care
Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respective ophthalmic therapeutic assets to form a unified entity focused on addressing ocular conditions associated with aging, including presbyopia, cataracts, and geographic atrophy. Key Therapeutics in the Combined…
VisiRose Unveils Non-Invasive Therapy for Keratitis
VisiRose, a newly established company formed in collaboration with Provectus Biopharmaceuticals and the Bascom Palmer Eye Institute (BPEI) at the University of Miami Miller School of Medicine, is advancing the development of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This…
Fluoxetine Improves Visual Acuity in Adult Amblyopia
A groundbreaking study conducted by researchers from the Eye Research Center, Farabi Eye Hospital, and Tehran University of Medical Sciences has revealed that fluoxetine, a commonly used antidepressant, significantly improves visual acuity (VA) in adults with amblyopia. The study, led…
ViaLase, Moran Eye Center Collaborate on Glaucoma
ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. This collaboration aims to accelerate glaucoma research by utilizing Moran’s state-of-the-art…
Dry Eye Disease Rates High in South America
Researchers from Colombia and Ecuador have identified that dry eye disease (DED)-related symptoms are more prevalent in South America compared to global averages, underscoring significant regional health challenges. The study, led by first author Valentina Loaiza-Guevara from the Facultad de…
Researchers Find 101 Genetic Links to Cataracts
In the largest genetic study on cataracts to date, researchers from QIMR Berghofer Medical Research Institute have identified 101 genetic regions associated with an increased risk of developing cataracts. This groundbreaking study analyzed DNA from over 950,000 individuals, providing significant…
Climate Change Linked to Eye Health Issues
A groundbreaking study from the University of Colorado Anschutz Medical Campus has identified a significant association between air pollution caused by climate change and an increase in ocular surface conditions. Clinical visits for these conditions more than doubled during periods…